What is the recommended dose of naltrexone (opioid receptor antagonist) for a patient with alcohol use disorder to reduce alcohol craving?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Naltrexone Dosing for Alcohol Craving

The recommended dose of naltrexone for reducing alcohol craving in patients with alcohol use disorder is 50 mg once daily orally, or alternatively 380 mg intramuscularly once monthly for the extended-release injectable formulation. 1, 2

Standard Oral Dosing Protocol

  • Start with 50 mg once daily after the patient has been abstinent from alcohol for at least 3-7 days and all withdrawal symptoms have completely resolved 3, 1

  • Some clinicians use a gradual initiation: 25 mg daily for days 1-3, then increase to 50 mg daily thereafter to minimize nausea 3, 1

  • Treatment duration should be 3-6 months, with consideration for extension up to 12 months based on clinical response 3, 1

Injectable Extended-Release Formulation

  • Vivitrol 380 mg intramuscularly once monthly is an alternative that may improve medication adherence compared to daily oral dosing 4, 2

  • The same timing requirements apply: patient must be abstinent and withdrawal-free before initiating 3

Critical Timing Requirements

Never initiate naltrexone during active alcohol withdrawal - this is a common and dangerous pitfall 3:

  • Naltrexone provides no benefit for withdrawal symptoms and delays appropriate benzodiazepine therapy 3

  • The patient must be completely opioid-free (including tramadol) for a minimum of 7-10 days before starting naltrexone to avoid precipitated withdrawal 1

  • Wait 3-7 days after last alcohol consumption and only after withdrawal management is complete 3

Mechanism and Expected Efficacy

  • Naltrexone functions as a competitive opioid receptor antagonist that blocks the euphoric effects of alcohol and reduces craving 4, 1

  • The number needed to treat to prevent return to any drinking is approximately 20, with a modest effect size of 0.15-0.2 2, 4, 5

  • In clinical trials, naltrexone reduced relapse rates from 54-60% (placebo) to 23-31% (naltrexone) when combined with psychosocial treatment 1, 6

Hepatotoxicity Concerns and Monitoring

  • Naltrexone undergoes hepatic metabolism and carries potential hepatotoxicity concerns, though this is uncommon at the standard 50 mg dose 2, 4

  • Obtain baseline liver function tests and monitor every 3-6 months during treatment 4, 3

  • Naltrexone is contraindicated in patients with acute hepatitis or decompensated cirrhosis 3

  • For patients with alcoholic liver disease, consider safer alternatives like baclofen (the only medication proven safe in cirrhotic patients) or acamprosate (no hepatic metabolism) 2, 3

Essential Contraindications

  • Active alcohol withdrawal syndrome 3

  • Current use of opioid medications for pain control 4

  • Acute hepatitis or decompensated cirrhosis 3

  • Patients requiring opioids should have oral naltrexone held for 2-3 days prior to elective procedures 4

Common Side Effects

  • Nausea is the most common adverse effect, occurring in a minority of patients 7, 8

  • Other side effects include headache, dizziness, and arthralgia 8

  • Serious side effects are uncommon when used at the standard 50 mg dose 1, 7

Integration with Comprehensive Treatment

Naltrexone is only effective as part of comprehensive treatment including psychosocial support, counseling, and mutual help groups like Alcoholics Anonymous 3, 8:

  • The medication supports abstinence and prevents relapse but does not work in isolation 1

  • Implement compliance-enhancing techniques for all treatment components, especially medication adherence 1

  • Naltrexone is not uniformly helpful to all patients and represents a modest improvement in conventional treatment outcomes 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Naltrexone Use in Alcohol Dependence

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Naltrexone Treatment for Alcohol Dependence

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Naltrexone in the treatment of alcohol dependence.

Archives of general psychiatry, 1992

Research

Naltrexone for the treatment of alcoholism.

American family physician, 1997

Related Questions

What is the recommended dosage of Naltrexone for a patient with a history of opioid or alcohol dependence, considering factors such as opioid-free status, renal impairment, and potential side effects?
What is the recommended starting dose of Naltrexone (opioid receptor antagonist) for a patient with alcoholism?
Is naltrexone (opioid receptor antagonist) used for managing alcohol withdrawal in patients with a history of alcohol dependence?
What is the recommended dosage and treatment regimen for Naltrexone (50mg) in patients with opioid and alcohol dependence?
What treatment options are available for a patient with alcohol use disorder who experiences frequent relapses?
Should clozapine be given as a nightly dose or split dose for a patient with treatment-resistant schizophrenia?
What is the recommended tapering schedule for an adult patient with anxiety or depression taking Lexapro (escitalopram) 10 mg?
What is the best approach to diagnose and manage a young female patient with generalized nonspecific aches and pains, fatigue, and weight gain?
What is the best course of action for a male patient with hypertension and chest pain, given a normal exercise stress test?
What is the recommended duration of meropenem and micafungin (antifungal medication) therapy for a severely ill, immunocompromised patient with ischemic bowel disease?
What oral anticoagulant can a patient with a history of thromboembolic events, currently on heparin (unfractionated heparin) three times a day, be switched to?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.